Trump wont mandate medicaid to cover glp-1s for obesity, some states still do

In recent months, South Carolina Medicaid made the decision to approve a new class of medications known as GLP-1s for the treatment of obesity. This move places the state among a select few that offer coverage for these effective yet costly drugs. However, despite this progress, access to these medications remains limited, even for patients who are covered by Medicaid. This is due to strict requirements that must be met before the drug can be prescribed